Side effect which paused Oxford, AstraZeneca clinical trial 'unlikely' related to COVID-19 vaccine
Oxford says a safety review into why a participant in the COVID-19 vaccine trial developed unexplained neurological symptoms including changed sensation or limb weakness found they were likely not linked to the shot.
No comments:
Post a Comment